帯状疱疹ワクチン|【公式】恵比寿いたみと内科のクリニック|渋谷区恵比寿のペインクリニック内科

〒150-0021東京都渋谷区恵比寿西1-10-10 若葉西ビル6階

03-6416-1204

WEB予約
診察室

帯状疱疹ワクチン

帯状疱疹ワクチン|【公式】恵比寿いたみと内科のクリニック|渋谷区恵比寿のペインクリニック内科

参考文献

  1. Oxman M.N., Levin M.J., Johnson G.R., et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia. New England Journal of Medicine. 2005;352(22):2271–2284.
  2. Lal H., Cunningham A.L., Godeaux O., et al. Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults (ZOE-50). New England Journal of Medicine. 2015;372(22):2087–2096.
  3. Cunningham A.L., Lal H., Kovac M., et al. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older (ZOE-70). New England Journal of Medicine. 2016;375(11):1019–1032.
  4. Schmader K.E., Levin M.J., Gnann J.W., et al. Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy. Clinical Infectious Diseases. 2012;55(10):1320–1328.
  5. Klein N.P., Bartlett J., Fireman B., et al. Effectiveness of the Live Zoster Vaccine During the 10 Years Following Vaccination: Real World Cohort Study Using Electronic Health Records. BMJ. 2023;383:e076321.
  6. Dooling K.L., Guo A., Patel M., et al. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. MMWR Morbidity and Mortality Weekly Report. 2018;67:103–108.
  7. Kawai K., Gebremeskel B.G., Acosta C.J. Systematic Review of Incidence and Complications of Herpes Zoster: Towards a Global Perspective. BMJ Open. 2014;4(6):e004833.
  8. Strezova A., Boutry C., Heineman T., et al. Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination (ZOSTER-049). Open Forum Infectious Diseases. 2022;9(10):ofac485.
  9. Cohen J.I. Clinical Practice: Herpes Zoster. New England Journal of Medicine. 2013;369(3):255–263.

TOP